{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:13:21Z","timestamp":1780463601738,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.vaccine.2010.04.001","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T13:07:40Z","timestamp":1272460060000},"page":"4312-4327","source":"Crossref","is-referenced-by-count":56,"title":["Optimal vaccine stockpile design for an eradicated disease: Application to polio"],"prefix":"10.1016","volume":"28","author":[{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March","key":"10.1016\/j.vaccine.2010.04.001_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.319.5870.1606","article-title":"Rinderpest. Driven to extinction","author":"Normile","year":"2008","journal-title":"Science"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.04.001_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1287\/mnsc.1080.0965","article-title":"Priority shifting and the dynamics of managing eradicable infectious disease","volume":"55","author":"Duintjer Tebbens","year":"2009","journal-title":"Management Science"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.04.001_bib3","first-page":"134","article-title":"Can measles be eradicated globally?","volume":"82","author":"de Quadros","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2010.04.001_bib4","unstructured":"Centers for Disease Control and Prevention. Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report December 31, 1993;42(RR-16)."},{"key":"10.1016\/j.vaccine.2010.04.001_bib5","unstructured":"Centers for Disease Control and Prevention. Global disease elimination and eradication as public health strategies. Morbidity and Mortality Weekly Report 1999;48(Suppl)."},{"key":"10.1016\/j.vaccine.2010.04.001_bib6","series-title":"Global polio vaccine stockpile review and analysis (unpublished report)","author":"Milstien","year":"2004"},{"issue":"1","key":"10.1016\/j.vaccine.2010.04.001_bib7","first-page":"117","article-title":"Antigen and vaccine banks: technical requirements and the role of the European antigen bank in emergency foot and mouth disease vaccination","volume":"26","author":"Lombard","year":"2007","journal-title":"Scientific and Technical Review"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2010.04.001_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1098\/rsif.2007.1152","article-title":"Antiviral treatment for the control of pandemic influenza: some logistical constraints","volume":"5","author":"Arinaminpathy","year":"2008","journal-title":"Journal of the Royal Society Interface"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.04.001_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3201\/eid1402.070478","article-title":"Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic","volume":"14","author":"Siddiqui","year":"2008","journal-title":"Emerging Infectious Diseases"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.04.001_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid1209.041344","article-title":"Potential impact of antiviral drug use during influenza pandemic","volume":"11","author":"Gani","year":"2005","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.vaccine.2010.04.001_bib11","unstructured":"World Health Organization. Global Polio Eradication Initiative, Programme of Work 2009 and Financial Resource Requirements 2009\u20132013 as of May 2009. Geneva; 2009. Report No.: WHO\/Polio\/09.02."},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.04.001_bib12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1539-6924.2006.00843.x","article-title":"Evaluation of response scenarios to potential polio outbreaks using mathematical models","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Analysis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.04.001_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.vaccine.2010.04.001_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0167-6296(96)00493-6","article-title":"Mathematical programming for the efficient allocation of health care resources","volume":"15","author":"Stinnet","year":"1996","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.vaccine.2010.04.001_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hec.793","article-title":"Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale","volume":"13","author":"Elbasha","year":"2004","journal-title":"Health Economics"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.04.001_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hec.1332","article-title":"Optimal drug pricing, limited use conditions and stratified net benefits for Markov models of disease progression","volume":"17","author":"Zaric","year":"2008","journal-title":"Health Economics"},{"key":"10.1016\/j.vaccine.2010.04.001_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0167-6296(03)00043-2","article-title":"Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis","volume":"22","author":"Brandeau","year":"2003","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.vaccine.2010.04.001_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hec.1286","article-title":"A note on the dynamic interaction between waiting times and waiting lists","volume":"17","author":"Siciliani","year":"2008","journal-title":"Health Economics"},{"key":"10.1016\/j.vaccine.2010.04.001_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhealeco.2005.12.002","article-title":"A dynamic model of supply of elective surgery in the presence of waiting times and waiting lists","volume":"25","author":"Siciliani","year":"2006","journal-title":"Journal of Health Economics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.04.001_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hec.1352","article-title":"The effects of stochastic demand and expense preference behaviour on public hospital costs and excess capacity","volume":"18","author":"Lovell","year":"2009","journal-title":"Health Economics"},{"key":"10.1016\/j.vaccine.2010.04.001_bib21","series-title":"Business dynamics: systems thinking and modeling for a complex world","author":"Sterman","year":"2001"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.04.001_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","article-title":"Retrospective cost-effectiveness analyses for polio vaccination in the United States","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Analysis"},{"issue":"April (9570)","key":"10.1016\/j.vaccine.2010.04.001_bib23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.04.001_bib24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2010.04.001_bib25","unstructured":"World Health Organization. Report of an informal consultation on the identification and management of vaccine-derived polioviruses (VDPVs). Geneva, Switzerland: Vaccines & Biologicals Department; 2004."},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.04.001_bib26","first-page":"35","article-title":"Policy decision options during the first 5 years following certification of polio eradication","volume":"5","author":"Sangrujee","year":"2003","journal-title":"Medscape General Medicine"},{"issue":"June (7)","key":"10.1016\/j.vaccine.2010.04.001_bib27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of global policies for managing polio after eradication","volume":"98","author":"Thompson","year":"2008","journal-title":"American Journal of Public Health"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2010.04.001_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.2005-2358","article-title":"Decision analysis in planning for a polio outbreak in the United States","volume":"118","author":"Jenkins","year":"2006","journal-title":"Pediatrics"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.04.001_bib29","first-page":"1106","article-title":"Ensuring preparedness for potential poliomyelitis outbreaks: recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP)","volume":"158","author":"Alexander","year":"2004","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1016\/j.vaccine.2010.04.001_bib30","unstructured":"Joint Working Group of the National Vaccine Advisory Committee (NVAC) and Advisory Committee on Immunization Practices (ACIP). Needs and recommendations for the United States poliovirus vaccine stockpile. National Vaccine Program Office, U.S. Department of Health and Human Services; 2004."},{"key":"10.1016\/j.vaccine.2010.04.001_bib31","series-title":"Exploring the role of antiviral drugs in the eradication of polio: workshop report","author":"Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication","year":"2006"},{"key":"10.1016\/j.vaccine.2010.04.001_bib32","unstructured":"World Health Organization. Standard operating procedures (SOPs) for the stockpile of monovalent oral poliovirus vaccines (mOPV) for the post-eradication\/post-OPV era. Geneva, Switzerland; September 27, 2007."},{"key":"10.1016\/j.vaccine.2010.04.001_bib33","unstructured":"World Health Organization. Global Polio Eradication Initiative: Strategic plan 2004\u20132008. Geneva; 2004."},{"key":"10.1016\/j.vaccine.2010.04.001_bib34","unstructured":"Global Alliance for Vaccines and Immunization. Investment case for the polio stockpile, June 20, 2005, <http:\/\/www.vaccinealliance.org\/resources\/16brd_07._Polio_Stockpile_investment_case.pdf>; [accessed 07.01.06]."},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.04.001_bib35","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1539-6924.2006.00844.x","article-title":"Containment of polioviruses after eradication: characterizing risk to improve management","volume":"26","author":"Dowdle","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2010.04.001_bib36","series-title":"WHO global action plan to minimize poliovirus facility-associated risk in the post-eradication\/post-OPV era","author":"World Health Organization","year":"2007"},{"issue":"8","key":"10.1016\/j.vaccine.2010.04.001_bib37","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"The Medscape Journal of Medicine"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.04.001_bib38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1539-6924.2008.01078.x","article-title":"Uncertainty and sensitivity analyses of a decision analytic model for post-eradication polio risk management","volume":"28","author":"Duintjer Tebbens","year":"2008","journal-title":"Risk Analysis"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.04.001_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.04.001_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1099-1751(199801\/03)13:1<5::AID-HPM497>3.0.CO;2-8","article-title":"Costs of polio immunization days in China: implications for mass immunization campaign strategies","volume":"13","author":"Zhang","year":"1998","journal-title":"International Journal of Health Planning and Management"},{"key":"10.1016\/j.vaccine.2010.04.001_bib41","series-title":"Viral infections of humans: epidemiology and control","first-page":"583","article-title":"Poliovirus and other enteroviruses","author":"Melnick","year":"1997"},{"key":"10.1016\/j.vaccine.2010.04.001_bib42","series-title":"Vaccines","first-page":"63","article-title":"Poliovirus vaccine\u2014live","author":"Sutter","year":"2008"},{"issue":"November (5597)","key":"10.1016\/j.vaccine.2010.04.001_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.1074674","article-title":"Containing bioterrorist smallpox","volume":"298","author":"Halloran","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.04.001_bib44","series-title":"Linear programming: foundations and extensions","author":"Vanderbei","year":"2001"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:17:18Z","timestamp":1711426638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10004949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":44,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0264410X10004949"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}